about
Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer.Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancerDevelopment and characterisation of acquired radioresistant breast cancer cell linesThe evolving role of receptors as predictive biomarkers for metastatic breast cancerOn-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancerUnlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches
P50
Q37174733-28535A95-13C1-4FCE-9826-95B46E454171Q38238648-05B5869E-F07E-40AC-A20E-1A103606FA91Q38704678-C0B6DC3A-0D54-4D13-A57A-08F263A2C139Q39237686-A0EB100A-8639-46AF-9012-E4D8E28D0B0AQ61445354-58D778F1-2FAB-4F19-9B9E-B6CD932745E8Q64115229-0882BB74-8AC3-42CC-B80C-B2EDC38F694FQ90009826-E9932C5A-03AB-4798-AECB-E499C9D52B0BQ92757615-BA4B1D6C-CA3D-41A9-991B-C7E7C465C5DFQ93009131-92FD0A6D-5AF8-4018-8A63-ABB914DB9E85
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlos Martínez-Pérez
@ast
Carlos Martínez-Pérez
@en
Carlos Martínez-Pérez
@es
Carlos Martínez-Pérez
@nl
type
label
Carlos Martínez-Pérez
@ast
Carlos Martínez-Pérez
@en
Carlos Martínez-Pérez
@es
Carlos Martínez-Pérez
@nl
prefLabel
Carlos Martínez-Pérez
@ast
Carlos Martínez-Pérez
@en
Carlos Martínez-Pérez
@es
Carlos Martínez-Pérez
@nl
P106
P1153
57057351000
P31
P496
0000-0002-4846-2832